Literature DB >> 31834031

Is there a problem with respect? Risk of neochordal rupture.

Sabin J Bozso1, Shubham D Shan, Jeevan Nagendran.   

Abstract

PURPOSE OF REVIEW: In this review, we summarize the history of mitral valve repair, discuss the broad principles of neochord preparation and implantation, and highlight comparative outcomes between mitral valve repair strategies while focusing on the risk of neochordal rupture. RECENT
FINDINGS: There have been several recent studies comparing outcomes been leaflet-resection and nonresection, neochord-based mitral valve repair. Operative mortality was very low regardless of repair strategy; however, the rate of mitral valve reoperation is lower in those that undergo a neochord-based repair with overall lower mean mitral gradients postrepair. The introduction of minimally invasive approaches to mitral valve repair has preferentially favored an increase in neochord-based repair, given the technical simplicity compared with resection-based approaches. In very rare cases, neochord rupture can occur, likely secondary to a combination of chordal calcification and mechanical stress.
SUMMARY: The method of performing mitral valve repair with neochord implantation has demonstrated superior durability over leaflet resection approaches with equivalent operative outcomes. Although the risk of neochord rupture exists, it is exceedingly rare, and should not be considered a limitation to a neochord-based mitral valve repair. Recurrent mitral regurgitation secondary to neochord rupture is incredibly rare; however, regular echocardiographic evaluation of these patients appears warranted, especially when follow-up extends over 10 years.

Entities:  

Mesh:

Year:  2020        PMID: 31834031     DOI: 10.1097/HCO.0000000000000705

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  1 in total

1.  Commentary: Neochord integrity: More than just initial breaking strength.

Authors:  William M DeCampli
Journal:  JTCVS Open       Date:  2021-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.